MOLN
Molecular Partners AG ADRNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$156.80M
P/E Ratio
—
EPS
$-1.97
Beta
0.74
52W High
$5.36
52W Low
$3.41
50-Day MA
$4.19
200-Day MA
$4.14
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
1.70
PEG Ratio
—
About Molecular Partners AG ADR
Molecular Partners AG is a clinical-stage biopharmaceutical company. The company is headquartered in Schlieren, Switzerland.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | $-39.14M |
| EBITDA | $-51.89M |
| Operating Margin | 0.00% |
| Return on Equity | -59.00% |
| Return on Assets | -28.80% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $2.32 |
| Price-to-Book | 1.80 |
| Price-to-Sales (TTM) | 156.56 |
| EV/Revenue | 3.814 |
| EV/EBITDA | 1.24 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -100.00% |
| Shares Outstanding | $37.51M |
| Float | $19.89M |
| % Insiders | 0.00% |
| % Institutions | 9.58% |
Historical Volatility
HV 10-Day
57.89%
HV 20-Day
53.51%
HV 30-Day
47.49%
HV 60-Day
53.57%
HV Rank
23.0%
Volatility is currently expanding
Analyst Ratings
Consensus ($11.12 target)
4
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026